Number of the records: 1
HPMA copolymer mebendazole conjugate allows systemic administration and possesses antitumour activity in vivo
- 1.
SYSNO 0558143 Title HPMA copolymer mebendazole conjugate allows systemic administration and possesses antitumour activity in vivo Author(s) Studenovský, Martin (UMCH-V) [BIOMOL] RID, ORCID
Rumlerová, Anna (UMCH-V) [BIOMOL]
Kovářová, Jiřina (MBU-M)
Dvořáková, Barbora (MBU-M) RID
Sivák, Ladislav (MBU-M) RID
Kostka, Libor (UMCH-V) [BIOMOL] RID, ORCID
Berdár, Daniel (MBU-M)
Etrych, Tomáš (UMCH-V) [BIOMOL] RID, ORCID
Kovář, Marek (MBU-M) RID, ORCIDCorespondence/senior Studenovský, Martin - Korespondující autor
Kovář, Marek - Korespondující autorSource Title Pharmaceutics. Roč. 14, č. 6 (2022). - : MDPI Article number 1201 Document Type Článek v odborném periodiku Grant GA19-05649S GA ČR - Czech Science Foundation (CSF), CZ - Czech Republic LTAUSA18083 GA MŠMT - Ministry of Education, Youth and Sports (MEYS), CZ - Czech Republic JSPS-22-01, CZ - Czech Republic, JP - Japan Institutional support UMCH-V - RVO:61389013 ; MBU-M - RVO:61388971 Language eng Country CH Keywords mebendazole * drug delivery * cancer therapy URL https://www.mdpi.com/1999-4923/14/6/1201 Permanent Link https://hdl.handle.net/11104/0333076
Number of the records: 1